Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP601007.RAzFl_1gxk7gntgvkPzMvayPYOV09ynBMBOFBUkUMd9s8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP601007.RAzFl_1gxk7gntgvkPzMvayPYOV09ynBMBOFBUkUMd9s8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP601007.RAzFl_1gxk7gntgvkPzMvayPYOV09ynBMBOFBUkUMd9s8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP601007.RAzFl_1gxk7gntgvkPzMvayPYOV09ynBMBOFBUkUMd9s8130_provenance.
- NP601007.RAzFl_1gxk7gntgvkPzMvayPYOV09ynBMBOFBUkUMd9s8130_assertion description "[Mutations of SLC2A2 were detected in historical FBS patients in whom some of the characteristic clinical features (hepatorenal glycogen accumulation, glucose and galactose intolerance, fasting hypoglycemia, a characteristic tubular nephropathy) and the effect of therapy were described for the first time.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP601007.RAzFl_1gxk7gntgvkPzMvayPYOV09ynBMBOFBUkUMd9s8130_provenance.
- NP601007.RAzFl_1gxk7gntgvkPzMvayPYOV09ynBMBOFBUkUMd9s8130_assertion evidence source_evidence_literature NP601007.RAzFl_1gxk7gntgvkPzMvayPYOV09ynBMBOFBUkUMd9s8130_provenance.
- NP601007.RAzFl_1gxk7gntgvkPzMvayPYOV09ynBMBOFBUkUMd9s8130_assertion SIO_000772 11810292 NP601007.RAzFl_1gxk7gntgvkPzMvayPYOV09ynBMBOFBUkUMd9s8130_provenance.
- NP601007.RAzFl_1gxk7gntgvkPzMvayPYOV09ynBMBOFBUkUMd9s8130_assertion wasDerivedFrom befree-20140225 NP601007.RAzFl_1gxk7gntgvkPzMvayPYOV09ynBMBOFBUkUMd9s8130_provenance.
- NP601007.RAzFl_1gxk7gntgvkPzMvayPYOV09ynBMBOFBUkUMd9s8130_assertion wasGeneratedBy ECO_0000203 NP601007.RAzFl_1gxk7gntgvkPzMvayPYOV09ynBMBOFBUkUMd9s8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP601007.RAzFl_1gxk7gntgvkPzMvayPYOV09ynBMBOFBUkUMd9s8130_provenance.